The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Even adding both stocks together is a massive loss for institutions. If this isn’t resolved with some upward movement in the next 12-18mths, Tils will struggle to raise a penny in the future. The BOD are under real pressure to perform or this will be just another pump and raise stock
Sharedealer….
This was never about money, that was clear the RTO details royally rogered everyone! I was quite happy to lose my possible £200, at the end of the day where can you tell board of directors you have been shambolic and this is my way of telling you straight! The cost of a trip to an AGM would have been more!! But this is without doubt as satisfying a conclusion we could have achieved. These fools will now been known for this crock for much longer than I will remember the money I lost. Who is going want a director that stabbed their shareholders in the front not back then wanted a sweetener deal for themselves! Steak and bubbly for me tonight!
Either way share holders have stood up to having their trousers pulled down whilst inept directors cream the results. Who knows if they come back with something else, however given that they have just raised 10 million at significant cost as fund raises are not a free service, they clearly will have to do something or the new business will be lumbered with some significant debts! Well done people, we will not be their urinal tonight or tomorrow. Sleep well
This is without doubt shambolic treatment by the current board, after months of positive spin about value and prospective rto candidates we are presented with this and treated with utter contempt. It’s like the ex threatening to take away your kids if you don’t agree to massive payments you can’t afford. Rock and hard place…
Same old waffle with no mention of value for previous shareholders, what a difference a RNS makes…… not
It’s now pretty obvious this RTO was all smoke and mirrors. With the greatest respect to BiVictriX, it’s purpose may be very noble but as pharma companies go it’s near the bottom of a growing pile. The ceo may be an amazing scientist but their staff profiles on LinkedIn highlight professionals who have literally just started their working life. Stood next to other AIM pharma boards you would be hard pressed to invest in here. People invest in people and they have to make you believe in their goal. If this was the best rto option the others must have been truly appalling. There’s a reason why the English chief medical officer is a person with decades of medical experience. I truly hope BiVictriX is a success but I doubt it. Will keep it on my watch list wait for the inevitable
novicehunter thanks for the correction, however you spell it, you cannot polish a turd! In fact the tax right off would be worth more! So it’s a vote no from me
RosieNas
The only thing worrying here, is that as RTOs go this is as damp any squid can possibly ever get......
Fools,
I think we should hold a view of mild skepticism until solid news is provided. At this rate the drift downwards will only resume without real news. IMO
It’s a long read and most of it covers the many risks of the business. Can’t see this going anywhere near £2 in the next 24 mth, if ever. The board have done well for themselves, it’s now time for them to show something for investors. The institutions that raised the last money, will not be so willing next time after reading this
One day in the not too distant future, we will be out out of our misery. However hope is eternal and we must keep in mind the previous board will no longer be sailing this ship. Overpaid and unquestionably underperforming
With advice like this you have just been given a one way ticket to the filtered box......my 2 week year old son clearly has more intelligence than anyone who thinks advice no context or content will be acted on! Yep I’ve acted. Goodbye
Well said sharedealer. Even if you think the board are sitting on their hands here, the prospective RTO candidate will not be. So expect a few fireworks once this all comes together. Their PR ramp crew will be banging the drum so loud for the first month or two SP will only go one way. Otherwise what’s the point of joining AIM
In my positive opinion. I’ve had 2 10baggers in last 12month so why not a third....
There is clearly other positive matters going on in the background which they haven’t disclosed yet. So not sure why they would only RNS a third of what is required? Who is the UK organization and what is the new share structure! If they were bothered about their investors they would be more up front. Why bother naming John Palmer but not the rest? Answers on a post card
I am positive, it could raise the sp exponentially over time, but given the ordeal all holders have had recently, it would have been nice if the buyer was in effect a ready to go operation. John Palmer is clearly a turnaround expert. Check his LinkedIn profile, so this will be another turnaround project. I cannot see this 50 or 10 bagging anytime soon. It appears the drawing board maybe be back out for our main and only product. Fingers crossed they get it right this time
Good news but it is still very smoke and mirrors? Out of all the possibles it went to a related party? Given they have already said it needs a massive fund raise to run further trials, I’m presuming they are super confident of raising this amount. The new guy has some history starting bio firms and selling them on so I’m presuming that’s their plan here. Mainly because I can’t see anything else they could do???? Where does all this leave the share price???